IP Series #5: IP Strategies for Protecting and Commercializing Biotech Inventions

IP Strategies for Protecting and Commercializing Biotech Inventions

The fate of intellectual property (IP) as it applies to commercialization is intricately connected to Patent prosecution decisions, and it can be sealed as early as the patent drafting stage. Understanding how patent law affects the scope of IP granted to the patentee and, consequently, the ability to commercialize the IP will inform inventors’ decision-making as early as experimental design, i.e., even prior to patent application filing.

Join Yvonne Shyntum, Partner at Pabst Patent Group, and Eric Bryant, Intellectual Property officer for the Center for Technology Licensing at Cornell, for this presentation focusing on Biotech IP.

Register here.